Moreover, FXR also showed effective therapeutic effect on nonalcoholic fatty liver disease (NAFLD) and metabolic diseases including obesity, diabetes, and hypercholesterolemia (Wang et al., 2018). The gene discussed is NR1H4; the disease is Other metabolic disease.